Austin, Texas
United States
7
2021-10-14
7
2022-02-01
These are the the leading inventors for applications assigned to Lumos Pharma, Inc.:
Lumos Pharma, Inc. based in Austin, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Detecting and treating growth hormone deficiency
#2 | 2020-09-10 ✅ Patent 11,485,705 granted on 2022-11-01Salts and prodrugs of 1-methyl-d-tryptophan
#3 | 2019-01-17 ✅ Patent 10,898,472 granted on 2021-01-26Detecting and treating growth hormone deficiency
#4 | 2018-12-13 ✅ Patent 10,377,721 granted on 2019-08-13Synthesis of cyclocreatine and analogs thereof
#5 | 2018-03-15 ✅ Patent 10,105,352 granted on 2018-10-23Detecting and treating growth hormone deficiency
#6 | 2018-02-15 ✅ Patent 10,081,605 granted on 2018-09-25Synthesis of cyclocreatine and analogs thereof
#7 | 2017-09-28 ✅ Patent 10,493,062 granted on 2019-12-03Synthesis of cyclocreatine and analogs thereof
Also check out Lumos Pharma, Inc.'s (Austin, United States) applicant profile with 7 patent applications submitted.
127043 ⎘